Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.68 |
| ▸ | CA1 | P00915 | 4/20 | 0.68 |
| ▸ | CA2 | P00918 | 4/20 | 0.68 |
| ▸ | CA7 | P43166 | 4/20 | 0.68 |
| ▸ | CA9 | Q16790 | 4/20 | 0.68 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.68 |
| ▸ | GAA | P10253 | 2/20 | 0.68 |
| ▸ | MAPT | P10636 | 2/20 | 0.68 |
| ▸ | POLB | P06746 | 1/20 | 0.68 |
| ▸ | CA4 | P22748 | 1/20 | 0.68 |
| ▸ | CA6 | P23280 | 1/20 | 0.68 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.68 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.68 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.67 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.60 |
| ▸ | DBH | P09172 | 1/20 | 0.58 |
| ▸ | RECQL | P46063 | 1/20 | 0.58 |
| ▸ | XDH | P47989 | 1/20 | 0.58 |
| ▸ | TOP1 | P11387 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10589365 | 0.91 | FASN (0.62) | CA12CA1CA2CA7CA9 | |
| SCHEMBL5476111 | 0.91 | MAPT (0.68) | CA12CA1CA2CA7CA9 | |
| SCHEMBL8861226 | 0.89 | SIRT1 (0.56) | CA12CA1CA2CA7CA9 | |
| SCHEMBL142204 | 0.89 | L3MBTL1 (0.64) | CA12CA1CA2CA7CA9 | |
| SCHEMBL31257839 | 0.89 | L3MBTL1 (0.64) | CA12CA1CA2CA7CA9 | |
| SCHEMBL6746043 | 0.87 | MAPK1 (0.63) | CA12CA1CA2CA7CA9 | |
| SCHEMBL6742077 | 0.87 | SIRT1 (0.59) | CA12CA1CA2CA7CA9 | |
| SCHEMBL6839571 | 0.87 | ALDH1A1 (0.67) | CA12CA1CA2CA7CA9 | |
| SCHEMBL30006432 | 0.87 | MAPK1 (0.63) | CA12CA1CA2CA7CA9 | |
| SCHEMBL6744685 | 0.87 | SIRT1 (0.59) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108727399-B | A kind of benzo dioxane indole derivatives and its preparation method and application | 福州大学 | 2019-06-07 | — | — | CN | claimed |
| CN-108602837-A | With the compound and its salt for inhibiting platelet aggregation effect and include its composition for preventing or treating thrombotic diseases | 新丰制药株式会社 | 2018-09-28 | — | — | CN | claimed |
| EP-0692733-B1 | Direct thermal recording process | AGFA GEVAERT NV (BE) | 1998-02-04 | — | — | EP | claimed |
| US-5582953-A | IMAGING LAYER CONTAINING SILVER SALTS AND ORGANIC DIHYDROXYL-CONTAINING REDUCING AGENT THEREFOR | AGFA-GEVAERT N.V. (BE) | 1996-12-10 | — | — | US | claimed |
| EP-0395346-B1 | Photosensitive composition | FUJI PHOTO FILM CO LTD (JP) | 1996-11-27 | — | — | EP | claimed |
| EP-0692733-A2 | Direct thermal recording process | AGFA-GEVAERT N.V. (BE) | 1996-01-17 | — | — | EP | claimed |
| US-5254432-A | Photosensitive composition | FUJI PHOTO FILM CO., LTD. (JP) | 1993-10-19 | — | — | US | claimed |
| US-5019612-A | Heat Resistance, Oxidation Resistance, Photostability, Polymers | CIBA-GEIGY CORPORATION (US) | 1991-05-28 | — | — | US | claimed |
| EP-0395346-A2 | Photosensitive composition | Fuji Photo Film Co., Ltd. (JP) | 1990-10-31 | — | — | EP | claimed |
| US-4015017-A | Certain biphenyl derivatives used to treat disorders caused by increased capillary permeability | LABORATOIRES PHARMASCIENCE (FR) | 1977-03-29 | — | — | US | claimed |
| US-12044969-B2 | Resist underlayer film-forming composition | NISSAN CHEMICAL CORPORATION (JP) | 2024-07-23 | — | — | US | disclosed |
| US-12044969-B2 | Resist underlayer film-forming composition | NISSAN CHEMICAL CORPORATION (JP) | 2024-07-23 | — | — | US | disclosed |
| US-11639325-B2 | Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-05-02 | — | — | US | disclosed |
| US-11639325-B2 | Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-05-02 | — | — | US | disclosed |
| CN-113795435-B | Soluble package of pre-measured powdered hair bleach | 莱雅公司 | 2023-04-25 | — | — | CN | disclosed |
| US-4732836-A | SOLUTION STABILITY PHENOLIC COMPOUNDS CONDENSED WITH QUINONES | HOECHST CELANESE CORPORATION (US) | 1988-03-22 | — | — | US | disclosed |
| EP-0244763-A2 | Positive-working photosensitive composition and photosensitive recording material prepared therefrom | HOECHST CELANESE CORPORATION (US) | 1987-11-11 | — | — | EP | disclosed |
| EP-0244762-A2 | Photosensitive positive composition and photosensitive registration material prepared therefrom | HOECHST CELANESE CORPORATION (US) | 1987-11-11 | — | — | EP | disclosed |
| EP-0243964-A2 | Photosensitive positive composition and photosensitive registration material prepared therefrom | HOECHST CELANESE CORPORATION (US) | 1987-11-04 | — | — | EP | disclosed |
| US-4015017-A | Certain biphenyl derivatives used to treat disorders caused by increased capillary permeability | LABORATOIRES PHARMASCIENCE (FR) | 1977-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11639325-B2 | Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders | HDAC1, HDAC10, HDAC6 | CA12 3937/4885CA1 1764/4885CA2 4324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.